Circulating activin-A is elevated in patients with advanced multiple myeloma and correlates with extensive bone involvement and inferior survival; no alterations post-lenalidomide and dexamethasone therapy. (Q53132270)
Jump to navigation
Jump to search
scientific article published on 6 April 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Circulating activin-A is elevated in patients with advanced multiple myeloma and correlates with extensive bone involvement and inferior survival; no alterations post-lenalidomide and dexamethasone therapy. |
scientific article published on 6 April 2012 |
Statements
Circulating activin-A is elevated in patients with advanced multiple myeloma and correlates with extensive bone involvement and inferior survival; no alterations post-lenalidomide and dexamethasone therapy. (English)
E Eleutherakis-Papaiakovou
E Terpos
D Christoulas
M Gkotzamanidou
N Kanellias
A Papatheodorou
6 April 2012
23
10
2681-2686
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference